HDL particle number fasting state
Selected indexed studies
- Update on the laboratory investigation of dyslipidemias. (Clin Chim Acta, 2018) [PMID:29336935]
- High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. (Lipids Health Dis, 2011) [PMID:22008512]
- PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding. (JHEP Rep, 2025) [PMID:40677694]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The role of advanced lipid testing in the prediction of cardiovascular disease. (2014) pubmed
- Update on the laboratory investigation of dyslipidemias. (2018) pubmed
- High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. (2011) pubmed
- PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding. (2025) pubmed
- Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. (2019) pubmed
- Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial. (2023) pubmed
- Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome. (2015) pubmed
- Association between empirically driven dietary patterns and cardiometabolic disease risk factors: a cross-sectional analysis in disease-free adults. (2025) pubmed
- The nuclear magnetic resonance metabolic profile: Impact of fasting status. (2021) pubmed
- Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. (2022) pubmed